PRISM for Depression and Anxiety in Young Adults with Cancer

Description

This research study is being done to test the feasibility of an existing supportive program (PRISM) to address psychological symptoms (i.e., depressive and anxiety symptoms) that young adult participants diagnosed with cancer or desmoid tumor may experience. The name of the intervention used in this research study is: -Promoting Resilience in Stress Management (PRISM) Program

Conditions

Cancer Diagnosis, Non-Metastatic Neoplasm, Anxiety, Anxiety Disorders, Depression, Depressive Disorder, Depression, Anxiety, Desmoid

Talk to us

Study Overview

On this page

Study Details

Study overview

This research study is being done to test the feasibility of an existing supportive program (PRISM) to address psychological symptoms (i.e., depressive and anxiety symptoms) that young adult participants diagnosed with cancer or desmoid tumor may experience. The name of the intervention used in this research study is: -Promoting Resilience in Stress Management (PRISM) Program

Treatment Development Study of the Promoting Resilience in Stress Management (PRISM) Intervention for Depression and Anxiety in Young Adults with Cancer

PRISM for Depression and Anxiety in Young Adults with Cancer

Condition
Cancer Diagnosis
Intervention / Treatment

-

Contacts and Locations

Brighton

Dana-Farber Cancer Institute, Brighton, Massachusetts, United States, 02135

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adults unable to consent, individuals who are not yet adults (age \<18), pregnant women, and prisoners.
  • * Individuals who score \<10 on both PHQ-9 and GAD-7.
  • * Patients who score \>14 (indicating moderately severe or severe depressive and/or anxiety symptoms) on PHQ-9 and/or GAD-7 will be ineligible for the current study but will be offered a referral to an appropriate mental health provider for support, if desired.
  • * Individuals who are treated with palliative intent for their disease, those who are diagnosed with cancer less than 6 weeks at the time of screening (we will be able to approach them again after 6 weeks since diagnosis has passed), or those who completed treatment more than 6 months ago will also be ineligible for this study; they will be offered resources for support, if desired.
  • * Individuals who report any suicidality (ideation, plan, and/or intent) at the time of the eligibility screening will also be excluded from the current study, and the appropriate safety measures and/or referral to a mental health provider will be made.

Ages Eligible for Study

18 Years to 30 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Dana-Farber Cancer Institute,

Samantha Bento, PhD, PRINCIPAL_INVESTIGATOR, Dana-Farber Cancer Institute

Greta Jankauskaite, PhD, STUDY_DIRECTOR, Dana-Farber Cancer Institute

Study Record Dates

2025-07-01